Trial Information

Summary: Clinical trial to test a study drug in people with Nonvalvular Atrial Fibrillation

The purpose of this study is to compare the safety and effectiveness of a study drug to warfarin in preventing stroke or clots in subjects with atrial fibrillation and risk factors for stroke.

Study drug and study procedures will be made available to you at no cost.

To qualify, you must:

  • Be at least 18 years old

You will not qualify if you:

  • Are pregnant or breast-feeding
  • Have moderate to severe mitral stenosis (narrowing)
  • Have planned major surgery
  • Have participated in a clinical trial within the past 30 days

    • Contact:

    Elena Pe, Research Coordinator
    Biomedical Research Alliance of New York
    Mount Sinai School of Medicine
    One Gustave L. Levy Place, Box # 1030
    New York, NY 10029
    Telephone: 212-241-7272
    Email:

    Profile Page: Biomedical Research Alliance of New York, New York, NY

    If you would like to learn more about participating in this study, please send an e-mail message using the form below.

    *Subject:

    Name:

    Address:

    City:

    State:

    *Zip:

    *Country:

    Phone:

    *Email address:

    Message:

    Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

    This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

    Trial listings updated: June 1, 2008 at 6:45:19 AM


    Back to Centerwatch Trial Listing by Location


    Additional resources
    in this illness area

    Copyright © 1995 - 2008, CenterWatch
    All Rights Reserved

    This site was developed in association with Illumina Interactive, Boston, MA